FAP and cholangiocarcinoma: There was no detectable FAP expression in only one CCA case (Figure 1A, 1.7%), whereas the majority of primary HCC, HCA, and FNH had no detectable FAP expression (57%, 76.9%, and 78.9%, respectively).